PHATHOM PHARMACEUTICALS, INC. (PHAT) Gross margin 2023–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.1%FY2025 · since FY2023: 75.5% → 87.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.1% | +1.5 pp |
| FY2024 | 85.6% | +10.1 pp |
| FY2023 | 75.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice